Cargando…

Synthesis and characterization of nanometer-sized liposomes for encapsulation and microRNA transfer to breast cancer cells

Introduction: The use of liposomes as a drug delivery carrier (DDC) for the treatment of various diseases, especially cancer, is rapidly increasing, requiring more stringent synthesis, formulation, and preservation techniques to bolster safety and efficacy. Liposomes otherwise referred to as phospho...

Descripción completa

Detalles Bibliográficos
Autores principales: Lujan, Henry, Griffin, Wezley C, Taube, Joseph H, Sayes, Christie M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6632672/
https://www.ncbi.nlm.nih.gov/pubmed/31371954
http://dx.doi.org/10.2147/IJN.S203330
_version_ 1783435708436840448
author Lujan, Henry
Griffin, Wezley C
Taube, Joseph H
Sayes, Christie M
author_facet Lujan, Henry
Griffin, Wezley C
Taube, Joseph H
Sayes, Christie M
author_sort Lujan, Henry
collection PubMed
description Introduction: The use of liposomes as a drug delivery carrier (DDC) for the treatment of various diseases, especially cancer, is rapidly increasing, requiring more stringent synthesis, formulation, and preservation techniques to bolster safety and efficacy. Liposomes otherwise referred to as phospholipid vesicles are self-assembled colloidal particles. When formed in either the micrometer or nanometer size range, they are ideal candidates as DDC because of their biological availability, performance, activity, and compatibility. Defining and addressing the critical quality attributes (CQAs) along the pharmaceutical production scale will enable a higher level of quality control for reproducibility. More specifically, understanding the CQAs of nanoliposomes that dictate its homogeneity and stability has the potential to widen applications in biomedical science. Methods: To this end, we designed a study that aimed to define synthesis, characterization, formulation (encapsulation), preservation, and cargo delivery and trafficking as the major components within a target product profile for nanoliposomes. A series of synthetic schemes were employed to measure physicochemical properties relevant to nanomaterial drug product development, including concentration gradients, probe versus bath sonication, and storage temperature measured by microscopy (electron and light) and dynamic light scattering. Results: Concentration was found to be a vital CQA as reducing concentrations resulted in nanometer-sized liposomes of <350 nm. Liposomes were loaded with microRNA and fluorescence spectroscopy was used to determine loading efficacy and stability over time. Lyophilization was used to create a dry powder formulation that was then assessed for stability for 6 months. Lastly, breast cancer cell lines were used to ensure efficacy of microRNA delivery and localization. Conclusion: We conclude that microRNA can be loaded into nanometer-sized liposomes, preserved for months in a dried form, and maintain encapsulation after extended time periods in storage.
format Online
Article
Text
id pubmed-6632672
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-66326722019-08-01 Synthesis and characterization of nanometer-sized liposomes for encapsulation and microRNA transfer to breast cancer cells Lujan, Henry Griffin, Wezley C Taube, Joseph H Sayes, Christie M Int J Nanomedicine Original Research Introduction: The use of liposomes as a drug delivery carrier (DDC) for the treatment of various diseases, especially cancer, is rapidly increasing, requiring more stringent synthesis, formulation, and preservation techniques to bolster safety and efficacy. Liposomes otherwise referred to as phospholipid vesicles are self-assembled colloidal particles. When formed in either the micrometer or nanometer size range, they are ideal candidates as DDC because of their biological availability, performance, activity, and compatibility. Defining and addressing the critical quality attributes (CQAs) along the pharmaceutical production scale will enable a higher level of quality control for reproducibility. More specifically, understanding the CQAs of nanoliposomes that dictate its homogeneity and stability has the potential to widen applications in biomedical science. Methods: To this end, we designed a study that aimed to define synthesis, characterization, formulation (encapsulation), preservation, and cargo delivery and trafficking as the major components within a target product profile for nanoliposomes. A series of synthetic schemes were employed to measure physicochemical properties relevant to nanomaterial drug product development, including concentration gradients, probe versus bath sonication, and storage temperature measured by microscopy (electron and light) and dynamic light scattering. Results: Concentration was found to be a vital CQA as reducing concentrations resulted in nanometer-sized liposomes of <350 nm. Liposomes were loaded with microRNA and fluorescence spectroscopy was used to determine loading efficacy and stability over time. Lyophilization was used to create a dry powder formulation that was then assessed for stability for 6 months. Lastly, breast cancer cell lines were used to ensure efficacy of microRNA delivery and localization. Conclusion: We conclude that microRNA can be loaded into nanometer-sized liposomes, preserved for months in a dried form, and maintain encapsulation after extended time periods in storage. Dove 2019-07-11 /pmc/articles/PMC6632672/ /pubmed/31371954 http://dx.doi.org/10.2147/IJN.S203330 Text en © 2019 Lujan et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Lujan, Henry
Griffin, Wezley C
Taube, Joseph H
Sayes, Christie M
Synthesis and characterization of nanometer-sized liposomes for encapsulation and microRNA transfer to breast cancer cells
title Synthesis and characterization of nanometer-sized liposomes for encapsulation and microRNA transfer to breast cancer cells
title_full Synthesis and characterization of nanometer-sized liposomes for encapsulation and microRNA transfer to breast cancer cells
title_fullStr Synthesis and characterization of nanometer-sized liposomes for encapsulation and microRNA transfer to breast cancer cells
title_full_unstemmed Synthesis and characterization of nanometer-sized liposomes for encapsulation and microRNA transfer to breast cancer cells
title_short Synthesis and characterization of nanometer-sized liposomes for encapsulation and microRNA transfer to breast cancer cells
title_sort synthesis and characterization of nanometer-sized liposomes for encapsulation and microrna transfer to breast cancer cells
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6632672/
https://www.ncbi.nlm.nih.gov/pubmed/31371954
http://dx.doi.org/10.2147/IJN.S203330
work_keys_str_mv AT lujanhenry synthesisandcharacterizationofnanometersizedliposomesforencapsulationandmicrornatransfertobreastcancercells
AT griffinwezleyc synthesisandcharacterizationofnanometersizedliposomesforencapsulationandmicrornatransfertobreastcancercells
AT taubejosephh synthesisandcharacterizationofnanometersizedliposomesforencapsulationandmicrornatransfertobreastcancercells
AT sayeschristiem synthesisandcharacterizationofnanometersizedliposomesforencapsulationandmicrornatransfertobreastcancercells